ArticleInorganic chemistry2026
Oxygen-Dependent Light-Induced Lipid Membrane Perturbation by TLD1433 as a Potential Contributor to Phototoxicity.
Article in Inorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
TLD1433 (Ruvidar®) is a Ru(II) polypyridyl complex currently in phase II clinical trials for the treatment of non-muscle invasive bladder cancer using photodynamic therapy (PDT). Previous studies have demonstrated that TLD1433 exhibits dual Type I/II photosensitization, arising from a combination of a prolonged intrinsic excited state lifetime and the redox-active α-terthienyl group, which together enable both singlet oxygen sensitization and light-driven redox processes. Despite this, molecular determinants contributing to its pronounced phototoxicity are still being elucidated. Herein, we investigated whether light-induced lipid membrane perturbation could represent a contributing photochemical property relevant to cytotoxic activity. To this end, all-atom molecular dynamics simulations and NMR experiments were employed to examine the insertion, partitioning, and residence of TLD1433 within a lipid bilayer in both dark and photoactivated states in normoxia and hypoxia, as well as the resulting effects on membrane structure integrity. Under normoxic conditions, oxidation events from the triplet excited state of TLD1433 promote localized accumulation of oxidized lipids and induce membrane deformations characterized by increased water penetration and transient pore-like features. In contrast, under low ROS-mediated lipid oxidation, membrane perturbations are more limited, although increased permeability and structural disorder are still observed. Taken together, these results suggest that light-induced lipid membrane perturbation, including poration, may represent a contributing factor to the phototoxic effects of TLD1433 under normoxic conditions. This combined computational and experimental study details how the photochemical properties of TLD1433 influence membrane response in a light- and oxygen-dependent manner, offering a framework for understanding how such effects may contribute to PDT efficacy at an unprecedented molecular level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.